[go: up one dir, main page]

LV10717A - Triazolpirimidina atvasinajumi to iegusanas panemieni sos atvasinajumus saturosas farmaceitiskas kompozicijas un panemieni sadu kompoziciju iegusanai - Google Patents

Triazolpirimidina atvasinajumi to iegusanas panemieni sos atvasinajumus saturosas farmaceitiskas kompozicijas un panemieni sadu kompoziciju iegusanai

Info

Publication number
LV10717A
LV10717A LV940060A LV940060A LV10717A LV 10717 A LV10717 A LV 10717A LV 940060 A LV940060 A LV 940060A LV 940060 A LV940060 A LV 940060A LV 10717 A LV10717 A LV 10717A
Authority
LV
Latvia
Prior art keywords
derivatives
triazolpyrimidine
preparations
compositions
derived
Prior art date
Application number
LV940060A
Other languages
English (en)
Other versions
LV10717B (en
Inventor
Nicole Bru-Magniez
Eric Nicolai
Jean-Marie Teulon
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of LV10717A publication Critical patent/LV10717A/lv
Publication of LV10717B publication Critical patent/LV10717B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-94-60A 1991-07-05 1994-03-29 Triazolopyrimidine derivatives, method for preparation thereof, pharmaceutical compositions containing them, methods for preparing these compositions LV10717B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9108486A FR2678618B1 (fr) 1991-07-05 1991-07-05 Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
LV10717A true LV10717A (lv) 1995-06-20
LV10717B LV10717B (en) 1995-12-20

Family

ID=9414783

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-60A LV10717B (en) 1991-07-05 1994-03-29 Triazolopyrimidine derivatives, method for preparation thereof, pharmaceutical compositions containing them, methods for preparing these compositions

Country Status (23)

Country Link
US (1) US5217973A (lv)
EP (1) EP0521768B1 (lv)
JP (1) JP3140566B2 (lv)
KR (1) KR100243628B1 (lv)
AT (1) ATE101153T1 (lv)
AU (1) AU655288B2 (lv)
CA (1) CA2072233C (lv)
CZ (1) CZ284757B6 (lv)
DE (1) DE69200045T2 (lv)
DK (1) DK0521768T3 (lv)
EE (1) EE03003B1 (lv)
ES (1) ES2063570T3 (lv)
FR (1) FR2678618B1 (lv)
HU (2) HU220225B (lv)
IE (1) IE65635B1 (lv)
IL (1) IL102367A (lv)
LV (1) LV10717B (lv)
MD (1) MD523G2 (lv)
NZ (1) NZ243443A (lv)
RU (1) RU2103270C1 (lv)
SK (1) SK279902B6 (lv)
TW (1) TW221445B (lv)
ZA (1) ZA924954B (lv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358950A (en) * 1991-07-05 1994-10-25 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists
US5387747A (en) * 1992-02-24 1995-02-07 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
FR2687677B1 (fr) * 1992-02-24 1996-10-11 Union Pharma Scient Appl Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5358947A (en) * 1993-09-13 1994-10-25 American Cyanamid Company Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones
AU743910B2 (en) * 1997-03-24 2002-02-07 Kyowa Hakko Kirin Co., Ltd. {1,2,4}triazolo{1,5-c}pyrimidine derivatives
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
WO2009158309A2 (en) * 2008-06-25 2009-12-30 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
HK1220696A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 鸟苷酸环化酶激动剂及其用途
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP4424697A3 (en) 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
US20240409538A1 (en) * 2021-10-19 2024-12-12 Impact Therapeutics (Shanghai), Inc. Substituted triazoloheteroaryl compounds as usp1 inhibitors and the use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US269980A (en) * 1883-01-02 Horse power
GB859287A (en) * 1958-10-03 1961-01-18 Ici Ltd Triazolopyrimidine derivatives and their preparation
GB897870A (en) * 1959-06-15 1962-05-30 Ici Ltd s-triazolo[2, 3-c]pyrimidine derivatives
GB951652A (en) * 1960-06-28 1964-03-11 Wallace Broadbent Sulphamyl triazolopyrimidines and their preparation
US4269980A (en) * 1979-12-17 1981-05-26 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4532242A (en) * 1983-05-02 1985-07-30 Riker Laboratories, Inc. Substituted triazolo[4,3-c]pyrimidines
US4528288A (en) * 1983-05-02 1985-07-09 Riker Laboratories, Inc. Substituted triazolo[1,5-c]pyrimidines
US4562192A (en) * 1984-02-03 1985-12-31 G. D. Searle & Co. 6-Substituted-5-phenyltetrazolo[1,5-a][1,2,4]triazole[1,5-c]pyrimidines, and pharmaceutical compositions containing them
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5010195A (en) * 1988-05-25 1991-04-23 The Dow Chemical Company Herbicidal alkoxy-1,2,4-triazolo(1,5-c)primidine-2-sulfonamides
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5177206A (en) * 1991-10-08 1993-01-05 Dowelanco Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides

Also Published As

Publication number Publication date
SK279902B6 (sk) 1999-05-07
ZA924954B (en) 1993-04-28
HU220225B (hu) 2001-11-28
HU9202227D0 (en) 1992-10-28
EP0521768A1 (fr) 1993-01-07
JP3140566B2 (ja) 2001-03-05
CA2072233C (en) 2003-11-18
CZ284757B6 (cs) 1999-02-17
MD523G2 (ro) 1997-01-31
MD523F1 (en) 1996-04-30
DE69200045T2 (de) 1994-05-19
RU2103270C1 (ru) 1998-01-27
HUT63422A (en) 1993-08-30
CZ207892A3 (en) 1993-01-13
CA2072233A1 (en) 1993-01-06
SK207892A3 (en) 1995-08-09
DE69200045D1 (de) 1994-03-17
ES2063570T3 (es) 1995-01-01
FR2678618B1 (fr) 1993-11-05
IL102367A0 (en) 1993-01-14
NZ243443A (en) 1995-01-27
TW221445B (lv) 1994-03-01
KR100243628B1 (ko) 2000-03-02
LV10717B (en) 1995-12-20
FR2678618A1 (fr) 1993-01-08
JPH06122685A (ja) 1994-05-06
AU655288B2 (en) 1994-12-15
HU211473A9 (en) 1995-11-28
KR930002349A (ko) 1993-02-23
DK0521768T3 (da) 1994-08-15
IE65635B1 (en) 1995-11-01
US5217973A (en) 1993-06-08
IE922015A1 (en) 1993-01-13
EP0521768B1 (fr) 1994-02-02
AU1939692A (en) 1993-01-07
EE03003B1 (et) 1997-06-16
ATE101153T1 (de) 1994-02-15
IL102367A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
LV10717A (lv) Triazolpirimidina atvasinajumi to iegusanas panemieni sos atvasinajumus saturosas farmaceitiskas kompozicijas un panemieni sadu kompoziciju iegusanai
RU92004368A (ru) Замещенные пиримидины, способ их получения, фармацевтическая композиция
RU94038256A (ru) Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе
GR3020866T3 (en) Indolocarbazole derivatives, processes for their preparation and their use
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
EE03046B1 (et) Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid
NZ215861A (en) Condensed triazole derivatives and pharmaceutical compositions
NZ220539A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IT1251496B (it) Derivati imidazotiadiazolici ad attivita' diuretica, procedimenti per la loro preparazione e composizioni che li contengono
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения
RU92016587A (ru) Новые производные бензопирана, активатор калиевого канала